首页> 外国专利> New n - hexamethylene imino alkyl acetates and n - (n - hexamethylene imino alkyl) - acetamides

New n - hexamethylene imino alkyl acetates and n - (n - hexamethylene imino alkyl) - acetamides

机译:新的正六亚甲基亚氨基烷基乙酸酯和正(正六亚甲基亚氨基烷基)乙酰胺

摘要

1384022 Hexamethyleneimines INNOTHERA 19 March 1973 [30 March 1972] 13161/73 Heading C2C Novel hexamethyleneimines of the general formula wherein R is a hydrogen atom or methyl or ethyl group, n is 0, 1, 2 or 3 and A is or R 1 R 2 CHCONH-, in which each of R 1 and R 2 is a straight or branched chain saturated C 1-6 aliphatic, allyl, cyclopentyl, cyclohexyl, cyclohexenyl, benzyl, halobenzyl, phenyl, halophenyl, methylphenyl, ethylphenyl, heterocyclyl or heterocyclylmethyl group, provided that when A is R 1 R 2 CHCOO- and one of R 1 and R 2 is a 3-thienyl group, the other is not a cyclopentyl, cyclohexyl, phenyl, halophenyl, methylphenyl or ethylphenyl group, including racemates and optical isomers, and quaternary ammonium pharmaceutically acceptable acid addition salts and derivatives thereof are prepared by condensing an acid of the general formula R 1 R 2 CHCOOH or a reactive functional derivative thereof with a hexamethyleneimine of the general formula wherein B is a halogen atom or hydroxyl or amino group. Acids of the second general formula above are prepared (a) by condensing mandelic acid, which may be substituted, with an appropriate benzene derivative in the presence of stannic chloride, (b) by condensing (by a malonic synthesis), optionally substituted ethyl phenylmalonate with benzyl chloride, which may be substituted, 2-chloromethylfuran or 2- or 3- chloromethyl-thiophene, followed by saponification and decarboxylation of the resulting malonic acid ester and (c) by reducing a glycollic acid of the general formula R 1 R 2 C(OH)COOH, obtained by condensing an appropriate glyoxylic acid with a Grignard reagent. Pharmaceutical compositions having spasmolytic and vasodilating activity comprise, as active ingredient, a hexamethyleneimine of the first general formula above or a pharmaceutically acceptable acid addition salt or quartenary ammonium derivative thereof, in association with a pharmaceutically acceptable carrier.
机译:1384022六亚甲基亚胺INNOTHERA 1973年3月19日[1972年3月30日]标题C2C通式为R 6的新型六亚甲基亚胺其中R为氢原子或甲基或乙基,n为0、1、2或3,A为或R 1 R 2 CHCONH-,其中R 1和R 2各自为直链或支链饱和的C 1-6脂族,烯丙基,环戊基,环己基,环己烯基,苄基,卤代苄基,苯基,卤代苯基,甲基苯基,乙基苯基,杂环基或杂环基甲基,条件是当A为R 1 R 2 CHCOO-且R 1和R 2之一为3-噻吩基时,另一个不是环戊基,环己基,苯基,卤代苯基,甲基苯基或乙基苯基,包括外消旋体和旋光异构体通过将通式为R 1 R 2 CHCOOH的酸或其反应性功能性衍生物与通式为B为卤素的六亚甲基亚胺缩合来制备可药用的季铵盐及其衍生物。原子或羟基或氨基。上面第二个通式的酸是这样制备的:(a)在氯化锡的存在下,用合适的苯衍生物缩合可被取代的扁桃酸,(b)通过缩合(丙二酸合成),将任选取代的苯丙二酸乙酯缩合来制备。用苄基氯(可被取代的2-氯甲基呋喃或2-或3-氯甲基噻吩),然后将所得丙二酸酯皂化和脱羧,以及(c)通过还原通式R 1 R 2的乙醇酸C(OH)COOH,通过将适当的乙醛酸与格氏试剂缩合而获得。具有解痉和血管舒张活性的药物组合物包含以上第一通式的六亚甲基亚胺或其药学上可接受的酸加成盐或季铵衍生物作为活性成分,以及药学上可接受的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号